Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
- Journal
- Psychopharmacology
In The Last Decade
doi.org/10.1007/bf02245606 →Countries where authors are citing Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
This map shows the geographic impact of Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding more than expected).
Fields of papers citing Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
This network shows the impact of Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
About Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
This paper, published in 1996, received 971 indexed citations . Written by Alain Schotte, Paul Janssen, W Gommeren, Walter Luyten, Paul Van Gompel, Anne Lesage and J.E. Leysen covering the research area of Molecular Biology and Cellular and Molecular Neuroscience. It is primarily cited by scholars working on Cellular and Molecular Neuroscience (519 citations), Psychiatry and Mental health (459 citations) and Molecular Biology (318 citations). Published in Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1007/bf02245606.